Bruker Corporation (BRKR)
NASDAQ: BRKR · Real-Time Price · USD
46.59
+1.93 (4.32%)
Dec 19, 2025, 11:43 AM EST - Market open
Bruker Revenue
Bruker had revenue of $860.50M in the quarter ending September 30, 2025, a decrease of -0.45%. This brings the company's revenue in the last twelve months to $3.44B, up 6.10% year-over-year. In the year 2024, Bruker had annual revenue of $3.37B with 13.56% growth.
Revenue (ttm)
$3.44B
Revenue Growth
+6.10%
P/S Ratio
1.97
Revenue / Employee
$301,764
Employees
11,396
Market Cap
7.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.37B | 401.90M | 13.56% |
| Dec 31, 2023 | 2.96B | 433.80M | 17.14% |
| Dec 31, 2022 | 2.53B | 112.80M | 4.67% |
| Dec 31, 2021 | 2.42B | 430.40M | 21.66% |
| Dec 31, 2020 | 1.99B | -85.10M | -4.11% |
| Dec 31, 2019 | 2.07B | 177.00M | 9.34% |
| Dec 31, 2018 | 1.90B | 129.70M | 7.34% |
| Dec 31, 2017 | 1.77B | 154.60M | 9.59% |
| Dec 31, 2016 | 1.61B | -12.50M | -0.77% |
| Dec 31, 2015 | 1.62B | -185.10M | -10.23% |
| Dec 31, 2014 | 1.81B | -30.50M | -1.66% |
| Dec 31, 2013 | 1.84B | 48.00M | 2.68% |
| Dec 31, 2012 | 1.79B | 139.70M | 8.46% |
| Dec 31, 2011 | 1.65B | 346.80M | 26.58% |
| Dec 31, 2010 | 1.30B | 190.40M | 17.08% |
| Dec 31, 2009 | 1.11B | 7.40M | 0.67% |
| Dec 31, 2008 | 1.11B | 74.70M | 7.24% |
| Dec 31, 2007 | 1.03B | 181.00M | 21.26% |
| Dec 31, 2006 | 851.40M | 479.15M | 128.72% |
| Dec 31, 2005 | 372.25M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
BRKR News
- 9 days ago - Bruker Announces Orders for High-Performance Magnetic Resonance Systems for Materials and Life-Science Research from Leading European Institutions - Business Wire
- 9 days ago - Bruker Corporation (BRKR) Presents at 53rd Annual Nasdaq Investor Conference Transcript - Seeking Alpha
- 11 days ago - Bruker Announces the Addition of Diagnostics Industry Leader Jack Phillips to its Board of Directors as of January 2026 - Business Wire
- 25 days ago - Indaba Capital Announces Sale of AST Revolution to Bruker - Business Wire
- 5 weeks ago - Q3 2025 Portfolio: Focusing On Resilience, Attractive Valuation And Sound Capital Allocation - Seeking Alpha
- 6 weeks ago - Bruker Announces Quarterly Common Stock Dividend and Preferred Stock Dividend - Business Wire
- 6 weeks ago - Bruker Corporation (BRKR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Bruker Reports Third Quarter 2025 Financial Results - Business Wire